Your Best Stock
Stocks MCK

McKesson MCK

US equityMarket cap rank #154Medical Distribution
$878.59
−$1.92 (-0.22%)
Market open · Sep 24, 1:10 pm ET
After hours $880.50 0.00%
Open$888.91
Prev close$880.50
Day range$877.06 – $896.60
Volume228.8K
Market cap$102.43B
P/E (TTM)23.5
Dividend yield0.37%

Fundamentals

Latest reported quarter: Q1, ended Jun 2026

Revenue$105.38B+7.7% YoY
Operating profit$1.42B+31.2% YoY
Net profit$1.03B+24.2% YoY
Diluted EPS$5.15-17.6% YoY
Free cash flow-$372.00M+66.4% YoY
Operating cash flow-$220.00M

Revenue, last 8 quarters

$93.7BSep '24$95.3BDec '24$90.8BMar '25$97.8BJun '25$103.2BSep '25$106.2BDec '25$96.3BMar '26$105.4BJun '26

Net profit, last 8 quarters

$287.0MSep '24$928.0MDec '24$1.3BMar '25$831.0MJun '25$1.2BSep '25$1.3BDec '25$1.9BMar '26$1.0BJun '26

Diluted EPS by quarter

1.87Sep '246.95Dec '2410.01Mar '256.25Jun '258.92Sep '259.59Dec '2513.71Mar '265.15Jun '26

Free cash flow by quarter

$1.9BSep '24$-2.6BDec '24$7.5BMar '25$-1.1BJun '25$2.2BSep '25$1.1BDec '25$3.2BMar '26$-372.0MJun '26

Annual revenue

$238.2BFY21$264.0BFY22$276.7BFY23$309.0BFY24$359.1BFY25$403.4BFY26

Profitability & balance sheet

Gross margin3.6%
Operating margin1.7%
Net margin1.1%
Return on assets5.4%
Current ratio0.89
Liabilities / assets101.5%
Cash & investments$5.16B
Total debt$11.41B
Net cash (debt)-$6.25B
Free cash flow / sales1.5%

Where the revenue comes from

Quarter 2027/Q1

By business line

  • North American Pharmaceutical$86.77B 82.3%
  • Oncology & Multispecialty$14.22B 13.5%
  • Medical-Surgical Solutions$2.82B 2.7%
  • Prescription Technology Solutions$1.57B 1.5%

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $105.38B $403.43B $96.30B $106.16B $103.15B
Total Operating Revenue $105.38B $403.43B $96.30B $106.16B $103.15B
Cost of Revenue $101.70B $388.88B $92.25B $102.47B $99.61B
Gross Profit $3.69B $14.55B $4.04B $3.69B $3.54B
Operating Expense $2.26B $8.10B $1.80B $2.03B $2.07B
Selling and Admin Expenses $2.26B $8.10B $1.80B $2.03B $2.07B
Operating Profit $1.42B $6.45B $2.25B $1.66B $1.47B
Net Non-Operating Interest Income (Expense) -$77.00M -$68.00M $118.00M -$63.00M -$74.00M
Non-Operating Interest Expense $77.00M $247.00M $61.00M $63.00M $74.00M
Other Income (Expense) -$36.00M -$185.00M -$241.00M $38.00M $1.00M
Special Income (Charges) -$102.00M -$242.00M -$98.00M -$36.00M -$61.00M
-Less:Restructuring and Mergern & Acquisition $89.00M $245.00M $99.00M $36.00M $63.00M
-Less:Impairment of Capital Assets $47.00M
-Less:Other Special Charges -$34.00M -$3.00M -$1.00M -$2.00M
Other Non-Operating Income (Expenses) $66.00M $44.00M -$156.00M $74.00M $62.00M
Pretax Profit $1.31B $6.20B $2.13B $1.63B $1.40B
Tax $276.00M $1.10B $270.00M $380.00M $232.00M
Net Profit $1.03B $5.10B $1.86B $1.25B $1.16B
Profit from Continuing Operations $1.03B $5.10B $1.86B $1.25B $1.16B
Minority Interests $418.00M $337.00M $173.00M $64.00M $53.00M
Net Income to Parent Company $614.00M $4.76B $1.68B $1.19B $1.11B
Net Income to Common Stockholders $614.00M $4.76B $1.68B $1.19B $1.11B
Basic EPS $5.17 $38.55 $13.78 $9.63 $8.95
Diluted EPS $5.15 $38.38 $13.71 $9.59 $8.92
Dividend Per Share $0.82 $3.17 $0.82 $0.82 $0.82
Non-Operating Interest Income $179.00M
Gain on Sale of Security $13.00M

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $88.33B $82.32B $82.32B $84.19B $84.16B
Total Current Assets $62.84B $57.21B $57.21B $59.70B $59.89B
Cash and Cash Equivalents & Short-Term Investments $5.16B $3.98B $3.98B $2.96B $4.00B
-Cash and Cash Equivalents $5.16B $3.98B $3.98B $2.96B $4.00B
Receivables $30.32B $27.99B $27.99B $28.21B $28.29B
-Accounts Receivable $30.32B $24.25B $24.25B $28.21B $28.29B
Inventory $26.26B $24.21B $24.21B $27.07B $26.13B
Other Current Assets $1.10B $1.04B $1.04B $1.46B $1.46B
Total Non-Current Assets $25.49B $25.11B $25.11B $24.49B $24.27B
Net PPE $4.63B $4.73B $4.73B $4.69B $4.62B
-Gross PPE $4.63B $7.34B $7.34B $4.69B $4.62B
Goodwill and Other Intangible Assets $15.29B $15.40B $15.40B $15.50B $15.50B
-Goodwill $11.28B $11.32B $11.32B $11.32B $11.28B
-Other Intangible Assets $4.01B $4.08B $4.08B $4.18B $4.22B
Other Non-Current Assets $5.58B $4.99B $4.99B $4.30B $4.15B
Total Liabilities $89.63B $83.16B $83.16B $84.29B $84.74B
Total Current Liabilities $70.36B $67.02B $67.02B $68.13B $68.03B
Payables $63.73B $59.97B $59.97B $60.68B $60.94B
-Accounts Payable $63.73B $59.97B $59.97B $60.68B $60.94B
Current Accrued Expenses $5.04B $5.49B $5.49B $6.03B $5.07B
Short-Term Debt and Capital Lease Obligation $1.59B $1.55B $1.55B $1.42B $2.03B
-Current Debt $1.30B $1.27B $1.27B $1.13B $1.75B
-Current Capital Lease Obligation $292.00M $287.00M $287.00M $286.00M $278.00M
Total Non-Current Liabilities $19.28B $16.14B $16.14B $16.16B $16.71B
Long Term Debt and Capital Lease Obligation $10.11B $7.06B $7.06B $7.21B $7.77B
-Long Term Debt $8.43B $5.26B $5.26B $5.43B $6.01B
-Long Term Capital Lease Obligation $1.68B $1.80B $1.80B $1.78B $1.76B
Non-Current Deferred Liabilities $1.36B $1.33B $1.33B $1.11B $1.09B
Other Non-Current Liabilities $7.80B $7.75B $7.75B $7.84B $7.85B
Total Equity -$1.30B -$834.00M -$834.00M -$99.00M -$578.00M
Stockholders' Equity -$4.24B -$2.17B -$2.17B -$1.30B -$1.74B
Capital Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Common Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $8.59B $8.28B $8.28B $8.55B $8.50B
Retained Earnings $22.81B $22.29B $22.29B $20.71B $19.62B
Less: Treasury Stock $34.89B $32.01B $32.01B $29.65B $28.96B
Gains/Losses Not Affecting Retained Earnings -$749.00M -$745.00M -$745.00M -$903.00M -$908.00M
Minority Interests $2.94B $1.34B $1.34B $1.20B $1.16B
-Other Receivables $4.00B $4.00B
-Receivables Adjustments Allowances -$259.00M -$259.00M
-Accumulated Depreciation -$2.61B -$2.61B

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow -$220.00M $6.16B $3.42B $1.23B $2.42B
Net cash flow from continuing operations -$220.00M $6.16B $3.42B $1.23B $2.42B
Net Income from Continuing Operations $1.03B $5.10B $1.86B $1.25B $1.16B
Gain/Loss from Continuing Operations -$6.00M -$573.00M -$488.00M $0.00 -$102.00M
Depreciation & Depletion & Amortization $195.00M $729.00M $196.00M $188.00M $188.00M
Deferred Tax $19.00M $230.00M $222.00M $49.00M -$33.00M
Other Non-Cash Items -$240.00M $572.00M -$395.00M $901.00M $111.00M
Change in Working Capital -$1.31B -$57.00M $1.97B -$1.01B $1.06B
-Change in Receivables -$2.37B -$2.00B $131.00M $166.00M -$207.00M
-Change in Inventory -$2.07B -$1.08B $3.02B -$899.00M -$1.23B
-Change in Payables and Accrued Expense $3.77B $4.32B -$574.00M -$279.00M $3.22B
-Change in Other Current Liabilities -$99.00M -$954.00M -$83.00M -$62.00M -$720.00M
-Change In Other Working Capital -$538.00M -$339.00M -$523.00M $63.00M -$13.00M
Net cash flow from investing -$214.00M -$3.43B $425.00M -$269.00M -$24.00M
Net Cash Flow from Continuing Investing Activities -$214.00M -$3.43B $425.00M -$269.00M -$24.00M
Capital Expenditure -$40.00M -$309.00M -$74.00M -$67.00M -$90.00M
Net PPE Purchase and Sale -$112.00M -$436.00M -$111.00M -$108.00M -$106.00M
Net Business Purchase and Sale -$14.00M -$2.59B $689.00M -$19.00M $99.00M
Net Other Investing Changes -$48.00M -$101.00M -$79.00M -$75.00M $73.00M
Financing Cash Flow $1.63B -$4.63B -$2.82B -$2.03B -$961.00M
Net Cash Flow from Continuing Financing Activities $1.63B -$4.63B -$2.82B -$2.03B -$961.00M
Net Issuance Payments Of Debt $3.21B $783.00M -$8.00M -$1.20B -$2.00M
Net Common Stock Issuance -$2.51B -$4.66B -$2.65B -$665.00M -$790.00M
Cash Dividends Paid -$102.00M -$381.00M -$101.00M -$101.00M -$89.00M
Net Other Financing Charges $1.03B -$372.00M -$64.00M -$63.00M -$80.00M
Ending Cash Balance $5.16B $3.98B $3.98B $2.96B $4.00B
Net Change in Cash $1.20B -$1.91B $1.03B -$1.06B $1.44B
Beginning Cash Balance $4.07B $5.96B $2.96B $4.00B $2.42B
Effect of Exchange Rate Changes -$10.00M $20.00M -$11.00M $7.00M -$9.00M
Free Cash Flow -$372.00M $5.41B $3.24B $1.06B $2.22B
Scroll to Top